相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Calcium dysregulation in Alzheimer's disease
Lukasz Bojarski et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
An update on the pharmacology of galantamine
Mercedes Villarroya et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Disease-modifying therapies for Alzheimer disease
Jeffrey L. Cummings et al.
NEUROLOGY (2007)
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease
Maria Laura Bolognesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Russell H. Swerdlow
NEUROBIOLOGY OF AGING (2007)
Huperzine a from Huperzia species -: an ethnopharmacolgical review
Xiaoqiang Ma et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
An update on the amyloid hypothesis
Christopher B. Eckman et al.
NEUROLOGIC CLINICS (2007)
Acetylcholinesterase inhibitors from plants
Pulok K. Mukherjee et al.
PHYTOMEDICINE (2007)
Herbal medicines to treat Alzheimer's disease
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Targeting acetylcholinesterase to treat neurodegeneration
Ulrike Holzgrabe et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias
Lina Holmquist et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Neurodegeneration and Alzheimer's disease: the lesson from tauopathies
G. Sorrentino et al.
NEUROLOGICAL SCIENCES (2007)
The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor
J. Meunier et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease
Hai Yan Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; Ladostigil
Moussa B. H. Youdim et al.
NEUROTOXICITY RESEARCH (2006)
Multifunctional drugs with different CNS targets for neuropsychiatric disorders
Cornelis J. Van der Schyf et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration
Maria L. Bolognesi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Therapeutic approaches to Alzheimer's disease
Hans-Wolfgang Klafki et al.
BRAIN (2006)
Alzheimer disease: progress or profit?
Claire Mount et al.
NATURE MEDICINE (2006)
Butyrylcholinesterase attenuates amyloid fibril formation in vitro
Sophia Diamant et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas
Johann Meunier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Immunology and immunotherapy of Alzheimer's disease
HL Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease
Agneta Nordberg
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Antigonadotropins: A novel strategy to halt Alzheimer's disease progression
CW Gregory et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Acetylcholinesterase inhibitors from plants and fungi
PJ Houghton et al.
NATURAL PRODUCT REPORTS (2006)
Progress in acetylcholinesterase inhibitors for Alzheimer's disease
Maria Laura Bolognesi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease
A Martinez et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Towards a unifying hypothesis of Alzheimer's disease: Cholinergic system linked to plaques, tangles and neuroinflammation
Kannan Sivaprakasam
CURRENT MEDICINAL CHEMISTRY (2006)
Pharmacological strategies for the prevention of Alzheimer's disease
PM Doraiswamy et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
One-compound-multiple-targets strategy to combat Alzheimer's disease
HY Zhang
FEBS LETTERS (2005)
New anti-Alzheimer drugs from biodiversity: The role of the natural acetylcholinesterase inhibitors
C Viegas et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Structural comparisons of meptazinol with opiold analgesics
W Li et al.
ACTA PHARMACOLOGICA SINICA (2005)
Rational approach to discover multipotent anti-Alzheimer drugs
M Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease
DR Liston et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Cholinesterase inhibitors: new roles and therapeutic alternatives
E Giacobini
PHARMACOLOGICAL RESEARCH (2004)
Combination therapy in Alzheimer's disease - A review of current evidence
B Schmitt et al.
CNS DRUGS (2004)
Endoplasmic reticulum Ca2+ homeostasis and neuronal death
A Verkhratsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2003)
Actylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer's disease
M Recanatini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2002)
分享论文
